Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids

D Czock, F Keller, FM Rasche, U Häussler - Clinical pharmacokinetics, 2005 - Springer
Glucocorticoids have pleiotropic effects that are used to treat diverse diseases such as
asthma, rheumatoid arthritis, systemic lupus erythematosus and acute kidney transplant …

Pharmacokinetic interactions with rifampicin: clinical relevance

M Niemi, JT Backman, MF Fromm, PJ Neuvonen… - Clinical …, 2003 - Springer
The antituberculosis drug rifampicin (rifampin) induces a number of drug-metabolising
enzymes, having the greatest effects on the expression of cytochrome P450 (CYP) 3A4 in …

Mycobacterium tuberculosis Infection in Solid-Organ Transplant Recipients: Impact and Implications for Management

N Singh, DL Paterson - Clinical infectious diseases, 1998 - academic.oup.com
Tuberculosis is a serious opportunistic infection in transplant recipients. On the basis of the
compilation of published reports in the literature, the incidence of Mycobacterium …

Infections in solid-organ transplant recipients

R Patel, CV Paya - Clinical microbiology reviews, 1997 - Am Soc Microbiol
Solid-organ transplantation is a therapeutic option for many human diseases. Infections are
a major complication of solid-organ transplantation. All candidates should undergo a …

Erythropoietin resistance: the role of inflammation and pro‐inflammatory cytokines

IC Macdougall, AC Cooper - Nephrology dialysis transplantation, 2002 - academic.oup.com
Up to 10% of patients with renal disease receiving recombinant human erythropoietin
(rHuEPO) therapy show poor responsiveness to the drug. Even in patients who do respond …

Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in spain1

JM Aguado, JA Herrero, J Gavaldá… - …, 1997 - journals.lww.com
Background. Tuberculosis is unusual in transplant recipients. The incidence, clinical
manifestations, and optimal treatment of this disease in this population has not been …

Rifampicin reduces effectiveness and bioavailability of prednisolone.

WA McAllister, PJ Thompson, SM Al-Habet… - Br Med J (Clin Res Ed …, 1983 - bmj.com
Rifampicin is an inducer of hepatic drug metabolising enzymes. This results in interactions
with several drugs including oral anticoagulants, hypoglycaemics, and contraceptives …

Clinical pharmacokinetics of prednisone and prednisolone

BM Frey, FJ Frey - Clinical pharmacokinetics, 1990 - Springer
The growth of knowledge in the field of the pharmacokinetics of prednisolone/prednisone
has been slow for several reasons. First, convenient and specific methods for measuring …

Mycobacterial infections in solid organ transplant recipients

Y Meije, C Piersimoni, J Torre‐Cisneros… - Clinical Microbiology …, 2014 - Wiley Online Library
Mycobacterial infections represent a growing challenge for solid organ transplant recipients
(SOT). The adverse effects of tuberculosis (TB) therapy present a major difficulty, due to the …

The spectrum of mycobacterial infection after lung transplantation

MA Malouf, AR Glanville - … journal of respiratory and critical care …, 1999 - atsjournals.org
Despite the success of lung transplantation, infection is one of the leading causes of
morbidity and mortality. Mycobacterial infections have been reported rarely, with the majority …